0HWG Stock Overview Provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
The Chemours Company Competitors Price History & Performance
Summary of share price highs, lows and changes for Chemours Historical stock prices Current Share Price US$17.51 52 Week High US$32.49 52 Week Low US$15.14 Beta 1.78 1 Month Change -15.53% 3 Month Change -6.46% 1 Year Change -45.65% 3 Year Change -44.96% 5 Year Change -1.41% Change since IPO -67.23%
Recent News & Updates
Investor sentiment improves as stock rises 16% Nov 25
Upcoming dividend of US$0.25 per share Nov 11 The Chemours Company Announces Unaudited Goodwill Impairment Charges for the Three Months Ended September 30, 2024
Third quarter 2024 earnings released: US$0.18 loss per share (vs US$0.14 profit in 3Q 2023) Nov 05
Second quarter dividend of US$0.25 announced Oct 27
The Chemours Company Declares Cash Dividend for the Fourth Quarter of 2024, Payable on December 16, 2024 Oct 25 See more updates
Investor sentiment improves as stock rises 16% Nov 25
Upcoming dividend of US$0.25 per share Nov 11 The Chemours Company Announces Unaudited Goodwill Impairment Charges for the Three Months Ended September 30, 2024
Third quarter 2024 earnings released: US$0.18 loss per share (vs US$0.14 profit in 3Q 2023) Nov 05
Second quarter dividend of US$0.25 announced Oct 27
The Chemours Company Declares Cash Dividend for the Fourth Quarter of 2024, Payable on December 16, 2024 Oct 25
The Chemours Company to Report Q3, 2024 Results on Nov 04, 2024 Oct 15
New major risk - Revenue and earnings growth Oct 07
High number of new directors Sep 25
The Chemours Company Announces Third Quarter Dividend, Payable on September 13, 2024 Jul 25
The Chemours Company to Report Q2, 2024 Results on Aug 01, 2024 Jul 12 The Chemours Company Resumes Production At Its Titanium Dioxide Site in Altamira, Mexico Jun 25
The Chemours Company Appoints Livingston Tony Satterthwaite to Its Board of Directors Jun 15 The Chemours Company Announces Executive Changes
The Chemours Company Enhances EVOLVE 2030 Portfolio Sustainability Assessment Methodology Jun 05 The Chemours Company Temporarily Pauses Titanium Dioxide Production At Altamira, Mexico Site Amid Severe Regional Drought Jun 02
Robbins Geller Rudman & Dowd LLP Files Lawsuit Against the Chemours Company May 16
The Chemours Company Provides Earnings Guidance for the Second Quarter of 2024 May 03
The Chemours Company Announces Dividend for the Second Quarter of 2024, Payable on June 14, 2024 Apr 30
The Chemours Company to Report Q1, 2024 Results on Apr 30, 2024 Apr 26
The Chemours Company, Annual General Meeting, May 21, 2024 Apr 12
The Chemours Company Provides Sales Guidance for the First Quarter of 2024 Mar 28
Bragar Eagel & Squire, P.C. Files Class Action Lawsuit Against The Chemours Company Mar 22 U.S. Department of Energy Grants $60 Million to Support Continued Advancement of Global Hydrogen Economy
The Chemours Company announced delayed annual 10-K filing Mar 02
The Chemours Company announced delayed annual 10-K filing Mar 01
Third quarter dividend of US$0.25 announced Feb 19
The Chemours Company Announces Changes to Its Board of Directors Feb 16
New minor risk - Share price stability Feb 16
The Chemours Company Announces Dividend for the First Quarter of 2024, Payable on March 15, 2024 Feb 14
The Chemours Company Announces Its Intention for Next-Generation Thermal Management Solutions At the HVAC&R Japan 2024 Jan 30
The Chemours Company to Report Q4, 2023 Results on Feb 14, 2024 Jan 19 Chemours, DuPont, and Corteva Provide Update and Affirm Support for PFAS Settlement with U.S. Water Systems Dec 22
The Chemours Company, Dupont De Nemours, Inc. and Corteva, Inc Announces Settlement Agreement with State of Ohio Nov 29
The Chemours Company Announces Changes to Its Board of Directors Nov 23
Upcoming dividend of US$0.25 per share at 4.0% yield Nov 07
Third quarter 2023 earnings released: EPS: US$0.14 (vs US$1.55 in 3Q 2022) Oct 28 The Chemours Company Provides Earnings Guidance for the Year Ending December 31, 2023 Singleton Schreiber Files Class Action Against Several Corporations Alleging Contamination of Private Water Supplies in Town of Campbell Oct 17
The Chemours Company to Report Q3, 2023 Results on Oct 26, 2023 Oct 07
The Chemours Company Announces Management Changes Sep 14
Chemours Announces Development of New Specialty Fluid for Two-Phase Immersion Cooling: Opteon™ 2P50 Aug 17
PureTech Scientific Inc. completed the acquisition of Glycolic Acid business of The Chemours Company. Aug 02
Chemours Company Announces Development of New Specialty Fluid for Two-Phase Immersion Cooling: Opteon 2P50 Aug 01 The Chemours Company Announces Closure of Titanium Dioxide Plant in Taiwan
Second quarter 2023 earnings released: US$2.52 loss per share (vs US$1.29 profit in 2Q 2022) Jul 28 The Chemours Company Declares Cash Dividend for the Third Quarter of 2023, Payable on September 15, 2023
The Chemours Company to Report Q2, 2023 Results on Jul 27, 2023 Jul 07 The Chemours Company, The Chemours Company FC, LLC, DuPont de Nemours, Inc., Corteva Inc. and E. I. du Pont de Nemours and Company enter Settlement Agreement Jul 03
The Chemours Company Appoints Brandon Ontjes as Vice President, Financial Planning & Analysis and Investor Relations Jun 28
The Chemours Company(NYSE:CC) dropped from Russell 1000 Growth Index Jun 25 Roosevelt County Water Coop Sues 3M, DuPont, Raytheon, Several Others Over PFAS Contamination Jun 13
The Chemours Company Announces Executive Changes Chemours, DuPont, and Corteva Reach Comprehensive PFAS Settlement with U.S. Water Systems Jun 03
PureTech Scientific Inc. agreed to acquire Glycolic Acid business of The Chemours Company for $137 million. Jun 02
Investor sentiment improves as stock rises 20% Jun 02
The Chemours Company Announces Executive Changes May 19
Upcoming dividend of US$0.25 per share at 3.5% yield May 05
First quarter 2023 earnings released: EPS: US$0.97 (vs US$1.46 in 1Q 2022) Apr 29 Shareholder Returns 0HWG GB Chemicals GB Market 7D -8.6% -2.6% -2.6% 1Y -45.7% -25.9% 2.4%
See full shareholder returns
Return vs Industry: 0HWG underperformed the UK Chemicals industry which returned -25.9% over the past year.
Return vs Market: 0HWG underperformed the UK Market which returned 2.4% over the past year.
Price Volatility Is 0HWG's price volatile compared to industry and market? 0HWG volatility 0HWG Average Weekly Movement 7.6% Chemicals Industry Average Movement 5.9% Market Average Movement 4.8% 10% most volatile stocks in GB Market 10.7% 10% least volatile stocks in GB Market 2.6%
Stable Share Price: 0HWG's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: 0HWG's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of UK stocks.
About the Company The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.
Show more The Chemours Company Fundamentals Summary How do Chemours's earnings and revenue compare to its market cap? 0HWG fundamental statistics Market cap US$2.65b Earnings (TTM ) US$76.00m Revenue (TTM ) US$5.75b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 0HWG income statement (TTM ) Revenue US$5.75b Cost of Revenue US$4.62b Gross Profit US$1.13b Other Expenses US$1.06b Earnings US$76.00m
Last Reported Earnings
Sep 30, 2024
Earnings per share (EPS) 0.51 Gross Margin 19.71% Net Profit Margin 1.32% Debt/Equity Ratio 605.8%
How did 0HWG perform over the long term?
See historical performance and comparison Dividends
5.6% Current Dividend Yield
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/21 01:03 End of Day Share Price 2024/12/20 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources The Chemours Company is covered by 20 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution null null Alembic Global Advisors David Coleman Argus Research Company Ishan Majumdar Baptista Research
Show 17 more analysts 